Peer Review History
| Original SubmissionJuly 12, 2024 |
|---|
|
PONE-D-24-27556 Characterizing physical activity bouts in people with stroke with different ambulation statuses PLOS ONE Dear Dr. Conradsson, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we have decided that your manuscript does not meet our criteria for publication and must therefore be rejected. I am sorry that we cannot be more positive on this occasion, but hope that you appreciate the reasons for this decision. Kind regards, Hidetaka Hamasaki Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The paper investigates how physical activity (PA) varies between stroke survivors with differing ambulatory capabilities and compares them with healthy controls. Using accelerometers, the study characterizes and contrasts daily PA patterns, frequencies, and intensities among limited community ambulators, community ambulators, and healthy controls. It has several strengths: • The paper addresses an important gap in the literature by exploring the PA patterns in post-stroke individuals with varying ambulation statuses, providing a nuanced understanding of their activity profiles. • The use of accelerometers (Actigraph GT3X+) for objective measurement of PA provides accurate and reliable data, enhancing the credibility of the findings. • The paper provides clear and practical recommendations for improving cardiovascular health in stroke survivors, emphasizing tailored interventions based on ambulation status. • Ethical considerations were well-addressed, including approval from the Regional Board of Ethics in Stockholm and informed consent from participants. However, it has a few major weaknesses: • Small Sample Size: The study only includes 39 participants post-stroke, limiting the generalisability of the findings to a broader population of stroke survivors. • Limited Diversity in Participants: The study's participants are predominantly younger and have fewer women than the typical stroke population in Sweden, potentially affecting the applicability of the findings. • MVPA Cutoff Limitations: The MVPA cutoff used was developed for healthy older adults and might underestimate the intensity of PA for those with more severe disabilities. This could lead to misclassification of activity intensity, especially for the LCA group. • Lack of Longitudinal Perspective: The study is cross-sectional, limiting the ability to infer causality or observe changes in PA patterns over time. • Methodological Differences: The paper mentions differences in accelerometer placement and PA bout definitions compared to previous studies, which may affect comparability. • Data Sharing Restrictions: The data availability statement indicates restrictions due to privacy concerns, limiting access for further validation and research. • Lack of Severe Cases: The exclusion of individuals with severe ambulation impairments limits the study’s applicability to all stroke survivors. In addition, a few minor comments 1. Language and Clarity: Some sections could benefit from clearer language to enhance readability. 2. Figures and Tables: Ensure all figures and tables are clearly labeled and referenced in the text for better comprehension. 3. Data Presentation: More detailed presentation of the data analysis methods could improve transparency and reproducibility. Overall, this paper is more suited for the audience in the specialist physiotherapy journal rather than PLOS ONE. Reviewer #2: The results presented in the current report require a more thorough and detailed analysis to fully understand their implications. It is essential to provide a comprehensive explanation of what the values signify in the context of the study. This includes interpreting the numerical data and explaining how these values relate to the objectives and hypotheses of the research. A detailed breakdown should include: Contextual Interpretation: Elaborate on how the values fit within the broader context of the study. This means discussing the relevance of these results to the research questions and how they align with or diverge from expected outcomes. Statistical Significance: Clarify the statistical significance of the results. Provide information on the confidence intervals, p-values, or other statistical metrics used to determine the reliability of the findings. Comparative Analysis: Compare the results with previous studies or benchmarks. Explain how these values contribute to or challenge existing knowledge in the field. Practical Implications: Discuss the practical implications of the results. What do these values mean for practitioners, stakeholders, or policymakers? How can they be applied in real-world scenarios? Visual Aids: Use graphs, charts, or tables to visually represent the data. This can help in making complex information more accessible and easier to understand. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: Yes: Kausik Chatterjee Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] - - - - - For journal use only: PONEDEC3 |
| Revision 1 |
|
PONE-D-24-27556R1Characterizing physical activity bouts in people with stroke with different ambulation statusesPLOS ONE Dear Dr. Conradsson, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please note that we have only been able to secure a single reviewer to assess your manuscript. We are issuing a decision on your manuscript at this point to prevent further delays in the evaluation of your manuscript. Please be aware that the editor who handles your revised manuscript might find it necessary to invite additional reviewers to assess this work once the revised manuscript is submitted. However, we will aim to proceed on the basis of this single review if possible. The reviewer has requested a range of clarifications regarding the reporting of categorization, assessment and scoring tools used, among other matters, as well as some additional discussion points. Please ensure you address each of the reviewer's comments when revising your manuscript. Please submit your revised manuscript by Apr 28 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Hugh Cowley Staff Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: “This study was supported by the Norrbacka-Eugenia foundation, Promobilia foundation, and NEURO Sweden.” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. In the online submission form, you indicated that [Since data can indirectly be traced back to the study participants, according to the Swedish and EU personal data sharing legislation, access can only be granted upon request from the Research Data Office at Karolinska Institute (rdo@ki.se). Any sharing of data will be regulated via a data transfer and use agreement with the recipient and require ethical approval from the Regional Board of Ethics in Stockholm.]. All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either 1. In a public repository, 2. Within the manuscript itself, or 3. Uploaded as supplementary information. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons on resubmission and your exemption request will be escalated for approval. Additional Editor Comments (if provided): [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #3: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #3: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #3: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #3: Firstly, I am grateful for the opportunity to review the manuscript entitled: Characterizing physical activity bouts in people with stroke with different ambulation statuses which aimed to characterize and contrast the daily patterns, frequency and intensity of physical activity bouts between people post stroke with different ambulation statuses compared to healthy controls. Here are some aspects to consider in relation to your manuscript in order to increase the quality of your manuscript. Abstract. In relation to the content of the abstract, it is important that the acronyms that appear are identifiable and that you have previously indicated what they refer to. It is especially suggested to pay attention to the acronyms LCA, CA, HC, MVPA, LIPA, which have not been previously indicated. Such indication should also be considered in the manuscript. Introduction. It is suggested that the categorisation of the sample should be better defined, as the way it is expressed in the document may lead to confusion. In the case of the ‘sedentary exercisers’ group, it would be those who exercise 0.7 hours/day or more. Where are the subjects who exercise between 0.7 hours/day and < 0.5 hours/day included? In the case of the ‘sedentary movers’ group, does it correspond to those subjects who do <0.5hours/day and > 0.1 hours/day? In the case of the ‘sedentary prolongers’ group, are they those who perform = or < 0.1 hours/day? It is really important that the categorisation of the sample is clearly stated in order to understand the results and the subsequent analysis and interpretation that follows. Study participants. In relation to the exclusion criteria, what assessment and scoring tools have been taken into account for the aspects of ‘cognitive impairments’, ‘severe neglect’ and ‘global aphasia’? It is recommended to provide such data to support the exclusion of participants. Clinical assessments and performance-based clinical test It is suggested that the authors provide the psychometric properties of the assessment tools used, as well as their validation and previous use in stroke survivors. Assessment of physical activity. It would be appreciated if the authors could provide a justification for the full 7-day monitoring with Actigraph GT3X+. Table 1. It is suggested that the authors include the data in relation to the group of ‘healthy controls’. Discussion. It would be appreciated to know why the use or non-use of assistive products has not been considered. On the other hand, it is suggested to provide such information in table 1. It is recommended to review the use of the term ‘basic activities of daily living’, it is mentioned 2 times in the discussion section. If it is linked to ‘walking’ it is important to reflect to which type of mobility it refers as well as which of them involve energy expenditure. Please provide information about the sample in relation to the performance of these basic activities. References. It is suggested that the authors update the references and include the most recent research and publications in both the introduction and the discussion. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
<p>Characterizing physical activity bouts in people with stroke with different ambulation statuses PONE-D-24-27556R2 Dear Dr. Conradsson, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Emiliano Cè, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #3: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #3: The authors have provided clarifications on the comments made and included the necessary changes to the manuscript in an appropriate manner. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #3: No ********** |
| Formally Accepted |
|
PONE-D-24-27556R2 PLOS ONE Dear Dr. Moulaee Conradsson, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Emiliano Cè Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .